NovaBay Pharmaceuticals Inc is a biotechnology business based in the US. NovaBay Pharmaceuticals shares (NBY) are listed on the NYSE MKT and all prices are listed in US Dollars. NovaBay Pharmaceuticals employs 22 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Active traders
Our top pick for
Beginners
Our top pick for
Building a portfolio
| Latest market close | $0.34 |
|---|---|
| 52-week range | $0.35 - $1.79 |
| 50-day moving average | $0.48 |
| 200-day moving average | $0.62 |
| Wall St. target price | $3.10 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.17 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.34 from 2022-01-14
| 1 week (2022-01-06) | N/A |
|---|---|
| 1 month (2021-12-16) | -24.44% |
| 3 months (2021-10-15) | -38.38% |
| 6 months (2021-07-16) | -41.38% |
| 1 year (2021-01-15) | -62.77% |
|---|---|
| 2 years (2020-01-17) | -45.87% |
| 3 years (2019-01-17) | 1.03 |
| 5 years (2017-01-17) | 3.7 |
| Revenue TTM | $7.7 million |
|---|---|
| Gross profit TTM | $6 million |
| Return on assets TTM | -31.66% |
| Return on equity TTM | -63.84% |
| Profit margin | -96.77% |
| Book value | $0.21 |
| Market capitalisation | $16.8 million |
TTM: trailing 12 months
We're not expecting NovaBay Pharmaceuticals to pay a dividend over the next 12 months.
NovaBay Pharmaceuticals's shares were split on a 1:25 basis on 20 December 2015. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NovaBay Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for NovaBay Pharmaceuticals shares which in turn could have impacted NovaBay Pharmaceuticals's share price.
Over the last 12 months, NovaBay Pharmaceuticals's shares have ranged in value from as little as $0.35 up to $1.79. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NovaBay Pharmaceuticals's is 3.4764. This would suggest that NovaBay Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.
NovaBay Pharmaceuticals, Inc. , a medical device company, develops products for the eye care markets in the United States and internationally. The company offers Avenova, a solution for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye, including the eyelid; CelleRx Clinical Reset, a gentle and soothing facial spray; and NeutroPhase and PhaseOne for the wound care market. It also offers KN95 Masks. The company sells its products through distribution partners, as well as offers Avenova and CelleRx Clinical Reset through online sales channels. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc.
Donut earns up to 10% APY, but you must have an iOS device.
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.